Drug Trials Snapshot: ROMVIMZA
Summary
The FDA approved ROMVIMZA based on safety and efficacy evidence from one clinical trial (NCT05059262) of 123 patients with TGCT. Learn more about the trial.
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.